Final Written Decisions in Pfizer’s IPR2021-00925 and IPR2021-00926 finding all challenged claims of uniQure’s U.S. Patent No. 9,982,248 (“the ’248 patent”) unpatentable (CAFC 23-1404 and 23-1405), ...

Oregon's ban on Project Veritas raises alarm bells for free speech advocates In a troubling development for free speech and whistleblower protection, various groups are rallying around Project Veritas ...

A growing number of women are claiming that Pfizer's widely-used contraceptive injection caused serious health problems, ...

California and three other states have called on the FDA to ease restrictions on the abortion pill mifepristone, which they ...

Women Seek Justice Over Depo-Provera’s Alleged Risks** In a significant legal challenge, nearly 300 women have filed lawsuits against Pfizer ...

A summary of current health news includes topics such as the Trump administration's inaccurate health report, China's ban on ...

Common use cases of AI in the supply chain illustrate the benefits for companies of integrating AI into their operations.

This summary of recent health news covers a U.S. government report error, China's ban on Brazilian poultry, legal action by ...

US Health Secretary Robert F. Kennedy Jr.'s decision to drop the Covid-19 vaccine from the CDC’s recommended immunization ...

Pfizer has abruptly ended its partnership with Acepodia, citing global resource shifts, not Acepodia’s competence. This split ...

Pfizer Inc. (NYSE: PFE) is navigating a period of strategic upheaval and legal scrutiny as it ends its clinical collaboration ...

Rep. Mark Green (R-TN) introduced the VITAL Act after a Senate report found Biden health officials downplayed the risk of myocarditis from COVID-19 vaccines.